JAZZ logo

Jazz Pharmaceuticals (JAZZ) Long term debt

Annual long term debt:

$6.12B+$949.37M(+18.37%)
December 31, 2024

Summary

  • As of today (May 21, 2025), JAZZ annual long term debt is $6.12 billion, with the most recent change of +$949.37 million (+18.37%) on December 31, 2024.
  • During the last 3 years, JAZZ annual long term debt has risen by +$10.44 million (+0.17%).
  • JAZZ annual long term debt is now at all-time high.

Performance

JAZZ Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

Quarterly long term debt:

$5.38B-$741.32M(-12.12%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ quarterly long term debt is $5.38 billion, with the most recent change of -$741.32 million (-12.12%) on March 1, 2025.
  • Over the past year, JAZZ quarterly long term debt has increased by +$213.99 million (+4.15%).
  • JAZZ quarterly long term debt is now -19.12% below its all-time high of $6.65 billion, reached on June 30, 2021.

Performance

JAZZ Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

JAZZ Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+18.4%+4.2%
3 y3 years+0.2%-11.5%
5 y5 years+254.6%+211.8%

JAZZ Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+18.4%-12.6%+4.2%
5 y5-yearat high+254.6%-19.1%+211.8%
alltimeall timeat high>+9999.0%-19.1%>+9999.0%

JAZZ Long term debt History

DateAnnualQuarterly
Mar 2025
-
$5.38B(-12.1%)
Dec 2024
$6.12B(+18.4%)
$6.12B(-0.6%)
Sep 2024
-
$6.15B(+19.0%)
Jun 2024
-
$5.17B(+0.1%)
Mar 2024
-
$5.16B(-0.1%)
Dec 2023
$5.17B(-10.4%)
$5.17B(-0.1%)
Sep 2023
-
$5.17B(-10.1%)
Jun 2023
-
$5.75B(-0.2%)
Mar 2023
-
$5.76B(-0.1%)
Dec 2022
$5.77B(-5.6%)
$5.77B(-0.1%)
Sep 2022
-
$5.77B(-4.9%)
Jun 2022
-
$6.07B(-0.1%)
Mar 2022
-
$6.08B(-0.5%)
Dec 2021
$6.11B(+207.1%)
$6.11B(-3.6%)
Sep 2021
-
$6.34B(-4.7%)
Jun 2021
-
$6.65B(+234.1%)
Mar 2021
-
$1.99B(+0.0%)
Dec 2020
$1.99B(+15.3%)
$1.99B(+0.1%)
Sep 2020
-
$1.99B(-10.3%)
Jun 2020
-
$2.21B(+28.4%)
Mar 2020
-
$1.72B(-0.1%)
Dec 2019
$1.73B(+10.4%)
$1.73B(+0.1%)
Sep 2019
-
$1.72B(+0.0%)
Jun 2019
-
$1.72B(+0.3%)
Mar 2019
-
$1.72B(+10.0%)
Dec 2018
$1.56B(+1.5%)
$1.56B(+0.2%)
Sep 2018
-
$1.56B(+0.1%)
Jun 2018
-
$1.56B(+1.4%)
Mar 2018
-
$1.54B(-0.2%)
Dec 2017
$1.54B(-22.7%)
$1.54B(-0.2%)
Sep 2017
-
$1.54B(-5.6%)
Jun 2017
-
$1.64B(-6.0%)
Mar 2017
-
$1.74B(-12.7%)
Dec 2016
$1.99B
$1.99B(-7.2%)
DateAnnualQuarterly
Sep 2016
-
$2.15B(+88.1%)
Jun 2016
-
$1.14B(-0.4%)
Mar 2016
-
$1.15B(-0.4%)
Dec 2015
$1.15B(-13.7%)
$1.15B(-1.8%)
Sep 2015
-
$1.17B(-12.4%)
Jun 2015
-
$1.34B(+0.2%)
Mar 2015
-
$1.33B(+0.1%)
Dec 2014
$1.33B(+144.9%)
$1.33B(+0.1%)
Sep 2014
-
$1.33B(+12.2%)
Jun 2014
-
$1.19B(-0.2%)
Mar 2014
-
$1.19B(+118.4%)
Dec 2013
$544.40M(+27.5%)
$544.40M(-0.2%)
Sep 2013
-
$545.56M(-0.2%)
Jun 2013
-
$546.72M(+30.6%)
Mar 2013
-
$418.51M(-2.0%)
Dec 2012
$427.07M(+1634.0%)
$427.07M(-2.0%)
Sep 2012
-
$435.63M(-1.9%)
Jun 2012
-
$444.19M(+2059.5%)
Mar 2011
-
$20.57M(-16.5%)
Dec 2010
$24.63M(-73.0%)
$24.63M(-24.7%)
Jun 2010
-
$32.69M(-59.0%)
Mar 2010
-
$79.82M(-12.4%)
Dec 2009
$91.11M(+21.3%)
$91.11M(-21.0%)
Sep 2009
-
$115.36M(+0.5%)
Jun 2009
-
$114.84M(+977.5%)
Mar 2009
-
$10.66M(-90.6%)
Sep 2008
-
$113.61M(-0.1%)
Jun 2008
-
$113.70M(+0.3%)
Mar 2008
-
$113.37M(+50.9%)
Dec 2007
$75.12M(+1.1%)
$75.12M(+0.3%)
Sep 2007
-
$74.86M(+0.3%)
Jun 2007
-
$74.62M(+0.3%)
Mar 2007
-
$74.43M(+0.2%)
Dec 2006
$74.28M(+0.9%)
$74.28M(+0.9%)
Dec 2005
$73.63M
$73.63M

FAQ

  • What is Jazz Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual long term debt year-on-year change?
  • What is Jazz Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly long term debt year-on-year change?

What is Jazz Pharmaceuticals annual long term debt?

The current annual long term debt of JAZZ is $6.12B

What is the all time high annual long term debt for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual long term debt is $6.12B

What is Jazz Pharmaceuticals annual long term debt year-on-year change?

Over the past year, JAZZ annual long term debt has changed by +$949.37M (+18.37%)

What is Jazz Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of JAZZ is $5.38B

What is the all time high quarterly long term debt for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly long term debt is $6.65B

What is Jazz Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, JAZZ quarterly long term debt has changed by +$213.99M (+4.15%)
On this page